Search Results 481-490 of 18336 for prednisone

  1. Oncology (Medical) - Clinical trials

    ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

  2. A Study to Evaluate Response Markers to Treat Rheumatoid Arthritis - Mayo Clinic

    Prednisone dose > 15mg per day within 7 days of blood draw. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  3. Fluconazole (intravenous route) - Side effects & uses - Mayo Clinic

    Prednisone; Ramelteon; Rifapentine; Rivaroxaban; Tretinoin; Trimetrexate; Vitamin A. Other Interactions. Certain medicines should not be used at or around the ...

  4. Lutetium lu 177 dotatate (intravenous route) - Mayo Clinic

    Prednisone. Show More. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  5. Dust mite allergy - Diagnosis & treatment - Mayo Clinic

    An allergic reaction is a red, itchy bump where the allergen was put on the skin. The most common side effects of these skin tests are itching and redness.

  6. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    ... prednisone 10 mg daily. Clinically-not controlled chronic or ongoing infectious disease requiring treatment at the time of first dose or within the 14 days ...

  7. A Study To Assess The Efficacy And Safety Of Efgartigimod IV In Adult Participants With Primary Immune Thrombocytopenia - Mayo Clinic

    ... prednisone, dexamethasone, other or nonspecified corticosteroids, IVIg, or anti-D immunoglobulin. Exclusion Criteria: * Other than the indication under study ...

  8. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Subjects who are currently using more than 5mg/day of prednisone (or an equivalent glucocorticoid exceeding physiologic replacement levels). Prior treatment ...

  9. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V - Mayo Clinic

    disease. Participants being treated with systemic corticosteroids for SLE or LN will be excluded if they have taken more than an average of 10 mg/day prednisone ...

  10. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    ... prednisone for 2 weeks if oral or 1 week if IV or ≥ 9 mg/day oral budesonide. Intolerance to CS therapy: History including, but not limited to, Cushing's ...